Catalase Market size is valued at USD 373.8 million in 2021 and is expected to grow at a CAGR of 3.2% from 2022 to 2028. The global market provides a detailed overview of the Catalase market, and that can be segmented by source, by end user, and by product. By source, the Catalase market has been segmented into Bovine Livers and Microorganisms. The Microorganisms segment is likely to be the largest and fastest-growing segment in terms of source. The microorganism source segment dominated in 2021 and is expected to show its dominance during the forecast period. The growth in the segment is attributable to the growing demand for fungi-based catalase from numerous end-users. Fungi-based catalases are suitable for a vegetarian diet, which is expected to increase demand for the product in the upcoming years. Alternatively, the bovine liver segment is anticipated to rise at an important pace during the forecast period. Exocrine pancreatic insufficiency, pancreatic cancer, and pancreatitis are among the situations that these products are used to cure. Consequently, it is predictable that during the forecast years, this will rise their demand in the global pharmaceutical business. Based on End-user, the Catalase market is segmented into Food & Beverage, Textile Industry, Personal Care, Pharmaceuticals, and Others. Among these, the viral Food & Beverage segment is expected to have the fastest-growing market during the forecast period 2022-2028. Based on end-user, the global catalase market is categorized into textile, food & beverages, pharmaceuticals, personal care, and others. The food & beverages industry is expected to hold the largest market share during the forecast period. The catalase enzyme is extremely suitable for usage in food and beverage businesses due to its capability to work as a food preservatives and its excellent tolerance to high pH levels. This substance is extremely useful in waste management and helps producers in dropping costs and food waste. The global catalase market is expected to be driven by these benefits. Based on the Product, the Catalase market is segmented into Liquid and Powder. The powder segment is expected to have a significant share in 2021.
In June 2021, Kerry partnered with BIO-CAT, Inc to take charge of a patented probiotic strain possessed by BIO-CAT, for sales, distribution, and marketing.
In May 2021, BRAIN Biotech AG expanded its business in the successful enzyme producer Biocatalysts Ltd.